Mechanisms Involved in the Genesis of Diabetic Nephropathy

被引:24
作者
Blazquez-Medela, Ana M. [1 ]
Lopez-Novoa, Jose M. [1 ]
Martinez-Salgado, Carlos [1 ,2 ]
机构
[1] Univ Salamanca, Dept Fisiol & Farmacol, Inst Reina Sofia Invest Nefrol, Unidad Fisiopatol Renal & Cardiovasc, Salamanca, Spain
[2] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain
关键词
Diabetes; Nephropathy; Gestational diabetes;
D O I
10.2174/157339910790909422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, the number of people suffering from diabetes has increased notably. This increase has led to an augmentation in secondary diseases; amongst them, diabetic nephropathy (DN) is one of the most relevant pathologies. DN provokes a decrease in glomerular filtration rate, which ends up in chronic renal failure. In the developed countries, DN is the first cause of chronic renal failure needing replacement therapy. Thus, this disease is responsible for a remarkable part of the public health costs in the Western countries. All of these facts have encouraged many scientists to perform their research on mechanism causing DN, improving our knowledge of its pathogenesis. In this review we summarize the most relevant facts on the physiopathology of DN.
引用
收藏
页码:68 / 87
页数:20
相关论文
共 415 条
[1]  
ADA, 2002, DIABETES CARE, V25, ps85, DOI [10.2337/diacare.25.2007.S85, DOI 10.2337/DIACARE.25.2007.S85]
[2]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[3]   Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions [J].
Advani, Andrew ;
Kelly, Darren J. ;
Advani, Suzanne L. ;
Cox, Alison J. ;
Thai, Kerri ;
Zhang, Yuan ;
White, Kathryn E. ;
Gow, Renae M. ;
Marshall, Sally M. ;
Steer, Brent M. ;
Marsden, Philip A. ;
Rakoczy, P. Elizabeth ;
Gilbert, Richard E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (36) :14448-14453
[4]   Effects of statins on renal function [J].
Agarwal, R .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (05) :748-755
[5]   Effects of statins on renal function [J].
Agarwal, Rajiv .
MAYO CLINIC PROCEEDINGS, 2007, 82 (11) :1381-1390
[6]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[7]  
[Anonymous], 1890, ARCH EXP PATHOL PHAR
[8]   The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study [J].
Athyros, VG ;
Mikhailidis, DP ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Elisaf, M .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) :728-734
[9]   Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption [J].
Azizi, M ;
Ménard, J ;
Bissery, A ;
Guyenne, TT ;
Bura-Rivière, A ;
Vaidyanathan, S ;
Camisasca, RP .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12) :3126-3133
[10]  
AZIZI M, 1994, J HYPERTENS, V12, P419